These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 9484857

  • 1. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM, Criscuoli M, Cucchi P, Giachetti A, Gianotti D, Giuliani S, Lecci A, Lippi A, Patacchini R, Quartara L, Renzetti AR, Tramontana M, Arcamone F, Maggi CA.
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [Abstract] [Full Text] [Related]

  • 2. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C, Tramontana M, Patacchini R, Lecci A, Catalani C, Catalioto RM, Meini S, Valenti C, Altamura M, Giuliani S, Maggi CA.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):140-8. PubMed ID: 16979621
    [Abstract] [Full Text] [Related]

  • 3. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R, Barthó L, Maggi CA.
    Br J Pharmacol; 1997 Dec 07; 122(8):1633-8. PubMed ID: 9422808
    [Abstract] [Full Text] [Related]

  • 4. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.
    Maggi CA, Astolfi M, Giuliani S, Goso C, Manzini S, Meini S, Patacchini R, Pavone V, Pedone C, Quartara L.
    J Pharmacol Exp Ther; 1994 Dec 07; 271(3):1489-500. PubMed ID: 7996462
    [Abstract] [Full Text] [Related]

  • 5. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    Patacchini R, Quartara L, Astolfi M, Goso C, Giachetti A, Maggi CA.
    J Pharmacol Exp Ther; 1995 Mar 07; 272(3):1082-7. PubMed ID: 7891319
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K.
    J Pharmacol Exp Ther; 2001 Jul 07; 298(1):307-15. PubMed ID: 11408556
    [Abstract] [Full Text] [Related]

  • 7. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
    Croci T, Aureggi G, Manara L, Emonds-Alt X, Le Fur G, Maffrand JP, Mukenge S, Ferla G.
    Br J Pharmacol; 1998 Jul 07; 124(6):1321-7. PubMed ID: 9720807
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
    Cirillo R, Astolfi M, Conte B, Lopez G, Parlani M, Sacco G, Terracciano R, Fincham CI, Sisto A, Evangelista S, Maggi CA, Manzini S.
    Neuropeptides; 2001 Jul 07; 35(3-4):137-47. PubMed ID: 11884203
    [Abstract] [Full Text] [Related]

  • 9. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA, Patacchini R, Meini S, Quartara L, Sisto A, Potier E, Giuliani S, Giachetti A.
    Br J Pharmacol; 1994 May 07; 112(1):150-60. PubMed ID: 7518302
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of the bicyclic peptide tachykinin NK2 receptor antagonist MEN 11420 (nepadutant) in rats.
    Lippi A, Criscuoli M, Guelfi M, Santicioli P, Maggi CA.
    Drug Metab Dispos; 1998 Nov 07; 26(11):1077-81. PubMed ID: 9806949
    [Abstract] [Full Text] [Related]

  • 11. Tachykinin NK2 receptors in the hamster urinary bladder: in vitro and in vivo characterization.
    Tramontana M, Patacchini R, Lecci A, Giuliani S, Maggi CA.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep 07; 358(3):293-300. PubMed ID: 9774215
    [Abstract] [Full Text] [Related]

  • 12. MEN 11420, a potent and selective tachykinin NK2 receptor antagonist in the guinea-pig and human colon.
    Santicioli P, Giuliani S, Patacchini R, Tramontana M, Criscuoli M, Maggi CA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov 07; 356(5):678-88. PubMed ID: 9402049
    [Abstract] [Full Text] [Related]

  • 13. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S, Nguyen-Le XK, Gobeil F, Pheng LH, Regoli D.
    Can J Physiol Pharmacol; 1997 Jun 07; 75(6):552-7. PubMed ID: 9276127
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
    Patacchini R, Quartara L, Rovero P, Goso C, Maggi CA.
    J Pharmacol Exp Ther; 1993 Jan 07; 264(1):17-21. PubMed ID: 8380857
    [Abstract] [Full Text] [Related]

  • 16. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J, Pinto FM, Anselmi E, Hernandez M, Perez-Afonso R, Martín JD, Advenier C, Candenas ML.
    Br J Pharmacol; 1998 Jan 07; 123(2):259-68. PubMed ID: 9489614
    [Abstract] [Full Text] [Related]

  • 17. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X, Proietto V, Steinberg R, Oury-Donat F, Vigé X, Vilain P, Naline E, Daoui S, Advenier C, Le Fur G, Maffrand JP, Soubrié P, Pascal M.
    J Pharmacol Exp Ther; 2002 Dec 07; 303(3):1171-9. PubMed ID: 12438541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of the antibronchoconstrictor activity of MEN 11420, a tachykinin NK2 receptor antagonist, in guinea-pigs.
    Tramontana M, Patacchini R, Giuliani S, Lippi A, Lecci A, Santicioli P, Criscuoli M, Maggi CA.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):279-88. PubMed ID: 9716365
    [Abstract] [Full Text] [Related]

  • 20. Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models.
    Lecci A, Carini F, Tramontana M, D'Aranno V, Marinoni E, Crea A, Bueno L, Fioramonti J, Criscuoli M, Giuliani S, Maggi CA.
    J Pharmacol Exp Ther; 2001 Oct 10; 299(1):247-54. PubMed ID: 11561086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.